Paul T. Spellman, Ph.D.

  • Professor of Molecular and Medical Genetics, School of Medicine
  • Co-Director, CEDAR, OHSU Knight Cancer Institute, School of Medicine
  • Co-leader, Quantitative Oncology Program, OHSU Knight Cancer Institute, School of Medicine
  • Molecular and Medical Genetics Graduate Program, School of Medicine
  • Cancer Biology Graduate Program, School of Medicine
  • Program in Molecular and Cellular Biosciences, School of Medicine
  • M.D./Ph.D. Program Committee, School of Medicine


Paul Spellman, Ph.D., is a professor in the Department of Molecular and Medical Genetics in the OHSU School of Medicine and co-leader of the Quantitative Oncology Program in the OHSU Knight Cancer Institute. He uses genetic and genomic approaches to understand the processes by which cancer develops, monitor disease, and to identify therapeutic strategies. He focuses on using population genetics to help determine who is at risk for cancer, how to computationally analyze genomic data to identify early changes in cancers, and how to accurately screen different populations for the disease. He also works to inform the public about the ways that genetics shape cancer risk. Spellman received his Ph.D. in genetics from Stanford University.

Education and training

Memberships and associations:

  • OHSU Center for Spatial Systems Biomedicine

Areas of interest

  • Genetics
  • Geonomics

Honors and awards

  • Penny and Phil Knight Professorship in Cancer Research Innovation



  • {{[0].value }}